Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yu Futami
Observed names:
Futami, Yu,
Y. Futami,
Y.N. Futami
Institutions:
Kinki Central Hospital,
The University of Osaka
Observed institutions:
Osaka Police Hospital,
Kinki Central Hospital,
Immunology Frontier Research Center, The University of Osaka,
The University of Osaka
ORCID:
0000-0002-1665-3474
Observed ORCID:
0000-0002-1665-3474
OpenAlex ID:
A5074901986
Works
17
Awards
1
Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients
2018
·
Akio Osa
, Takeshi Uenami
, et al.
·
JCI Insight
·
232
PDF
Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres
2021
·
Taro Koba
, Yoshito Takeda
, et al.
·
ERJ Open Research
·
39
PDF
Pathological and therapeutic implications of eosinophil-derived semaphorin 4D in eosinophilic chronic rhinosinusitis
2020
·
Takeshi Tsuda
, Masayuki Nishide
, et al.
·
Journal of Allergy and Clinical Immunology
·
26
SFTPB in serum extracellular vesicles as a biomarker of progressive pulmonary fibrosis
2024
·
Takatoshi Enomoto
, Yuya Shirai
, et al.
·
JCI Insight
·
24
Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles
2022
·
Yu Futami
, Yoshito Takeda
, et al.
·
International Immunology
·
24
PDF
IL-33 Induces Sema4A Expression in Dendritic Cells and Exerts Antitumor Immunity
2021
·
Yasuhiko Suga
, Izumi Nagatomo
, et al.
·
The Journal of Immunology
·
22
Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer
2024
·
Takashi Hirai
, Yujiro Naito
, et al.
·
JCI Insight
·
10
PDF
Serum vesicle biomarkers reflect the disease activity of idiopathic pulmonary fibrosis
2025
·
Yuya Shirai
, Takatoshi Enomoto
, et al.
·
Journal of Translational Medicine
·
4
PDF
Leucine-rich a-2 glycoprotein as a potential biomarker of idiopathic multicentric Castleman disease with pulmonary involvement: a single-center case-control study from Japan
2022
·
So Takata
, Yoshito Takeda
, et al.
·
Journal of Thoracic Disease
·
2
PDF
Proteomic Profiling of Serum Exosomes to Identify Novel Biomarkers for COPD
2019
·
T. Koba
, Y. Takeda
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
2
Proteomic Profiling of Serum Exosomes to Find Novel Biomarkers in Sarcoidosis
2019
·
Y. Futami
, Y. Takeda
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
2
Target Proteomics Identifies Novel Biomarkers from Serum Exosomes in Sarcoidosis
2020
·
Y. Futami
, Y. Takeda
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Targeted Proteomics of Serum Extracellular Vesicles to Identify Novel Biomarkers for COPD
2020
·
T. Koba
, Y. Takeda
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Quantitative Proteomics of Serum Exosomes to Identify Novel Biomarkers for Mycobacterium Avium Complex and Tuberculosis
2020
·
R. Edahiro
, Y. Takeda
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for previously untreated advanced non-squamous non-small cell lung cancer
2017
·
T. Uenami
, T. Koba
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
17
Citation count:
387
H-index:
7
I10-index:
7
Year
Topic
Type
